Special Investigation for VIZIMPRO Tablets (Secondary Data Collection Study; Safety and Efficacy of VIZIMPRO Under Japanese Medical Practice)

Clinical trial NCT04155541 · COMPLETED

Trial details

NCT number: NCT04155541
Sponsor: Pfizer
Status: COMPLETED
Study type: OBSERVATIONAL

EGFR Mutation-positive Inoperable or Reccrent NSCLC

Start date: 2020-01-24
Primary completion: 2025-04-25
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.